Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000351739

Medchemexpress LLC Zanzalintinib | 2367004-54-2 | 99.91% | 528.53 | 50 MG
SDP

Catalog No. 5000351739
Encompass_Preferred

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL, and MER. It exhibits anti-tumor activity and has potential for research in kinase-dependent diseases and conditions.

  • Orally active, ATP-competitive inhibitor
  • Targets MET, VEGFR2, AXL, and MER
  • Exhibits anti-tumor activity
  • Potential for kinase-dependent diseases and conditions research

Catalog No. 50-003-51739 Supplier Medchemexpress LLC Supplier No. HY13869650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL, and MER. It exhibits anti-tumor activity and has potential for research in kinase-dependent diseases and conditions.

  • Orally active, ATP-competitive inhibitor
  • Targets MET, VEGFR2, AXL, and MER
  • Exhibits anti-tumor activity
  • Potential for kinase-dependent diseases and conditions research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.